Literature DB >> 2831929

Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.

V M Macauly1, J D Teale, M J Everard, G P Joshi, I E Smith, J L Millar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2831929      PMCID： PMC2246693          DOI： 10.1038/bjc.1988.16

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  22 in total

1.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Authors:  M Brower; D N Carney; H K Oie; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

2.  Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium.

Authors:  E Simms; A F Gazdar; P G Abrams; J D Minna
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

3.  Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C.

Authors:  W E Russell; J J Van Wyk; W J Pledger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Establishment and identification of small cell lung cancer cell lines having classic and variant features.

Authors:  D N Carney; A F Gazdar; G Bepler; J G Guccion; P J Marangos; T W Moody; M H Zweig; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

5.  Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.

Authors:  S Weber; J E Zuckerman; D G Bostwick; K G Bensch; B I Sikic; T A Raffin
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

6.  Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.

Authors:  R C Baxter; A S Brown; J R Turtle
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

7.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

Authors:  A J D'Ercole; A D Stiles; L E Underwood
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II.

Authors:  H Marquardt; G J Todaro; L E Henderson; S Oroszlan
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

9.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

Authors:  F Cuttitta; D N Carney; J Mulshine; T W Moody; J Fedorko; A Fischler; J D Minna
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

10.  A high molecular weight non-bombesin/gastrin releasing peptide growth factor in small cell lung cancer.

Authors:  V Macaulay; G P Joshi; M Everard; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
View more
  11 in total

Review 1.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

2.  Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma.

Authors:  C L Williams; V A Lennon
Journal:  Cell Regul       Date:  1991-05

3.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 4.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

5.  Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factor.

Authors:  H Kobayashi; H Sakahara; M Hosono; M Shirato; J Konishi; J A Takahashi; Y Oda; H Kikuchi; K Endo; Y Kozai
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

6.  Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.

Authors:  K Aizawa; I Muto; S Suzuki; N Tanaka; H Yabusaki; S Tanaka; N Katayanagi; T Suzuki; O Tanaka; T Muto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone.

Authors:  J M Siegfried; P G Kasprzyk; A M Treston; J L Mulshine; K A Quinn; F Cuttitta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.

Authors:  V M Macaulay; I E Smith; M J Everard; J D Teale; J C Reubi; J L Millar
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

9.  Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.

Authors:  J Pinski; A V Schally; G Halmos; K Szepeshazi; K Groot; K O'Byrne; R Z Cai
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis.

Authors:  M Nishimura; K Machida; M Imaizumi; T Abe; T Umeda; E Takeshima; T Watanabe; Y Ohnishi; K Takagi; M Hamaguchi
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.